Showing results (21-30 of 320) with videos related to
Sort By:
Pageof 32
Cancer|January 20, 2007
Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemiaYasuhiro Oki, Hagop M Kantarjian, Vazganush Gharibyan, et al.Blood|July 23, 2005
JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemiaJaroslav Jelinek, Yasuhiro Oki, Vazganush Gharibyan, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 6, 2011
Time to think outside the (genetic) boxJean-Pierre J Issa, Judy E GarberGenome Medicine|November 26, 2009
Tackling the methylome: recent methodological advances in genome-wide methylation profilingMarcos Rh Estécio, Jean-Pierre J IssaClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Targeting DNA methylationJean-Pierre J Issa, Hagop M KantarjianCurrent Opinion in Genetics & Development|April 17, 2017
The promise of epigenetic therapy: reprogramming the cancer epigenomeAndrew D Kelly, Jean-Pierre J IssaSeminars in Hematology|July 15, 2005
Decitabine dosing schedulesHagop M Kantarjian, Jean-Pierre J IssaEpigenomes|June 25, 2025
DNA Methylation, Aging, and CancerHimani Vaidya, Jaroslav Jelinek, Jean-Pierre J IssaFEBS Letters|December 15, 2010
Dissecting DNA hypermethylation in cancerMarcos R H Estécio, Jean-Pierre J IssaPageof 32